Zydus receives final approval from the USFDA for Itraconazol Capsule 100 mg

Zydus receives final approval from the USFDA for Itraconazole Capsules 100 mg Ahmedabad, 21 September 2017 Zydus Cadila has received the final approval from the USFDA to market Itraconazole Capsules 100 mg . The drug is used to treat a variety of fungal infections and will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad. The group now has more than 150 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04. ***

The release as fetched from its publisher. zyduslife.com ↗